Reply to Francesco Montorsi, Alessandro Larcher, and Umberto Capitanio's Letter to the Editor re: Rohann J.M. Correa, Alexander V. Louie, Nicholas G. Zaorsky, et al. The Emerging Role of Stereotactic Ablative Radiotherapy for Primary Renal Cell Carcinoma: A Systematic Review and Meta-Analysis. Eur Urol Focus. 2019 Jun 24. pii: S2405-4569(19)30157-9. https://doi.org/10.1016/j.euf.2019.06.002. [Epub ahead of print]
1 Department of Radiation Oncology, London Regional Cancer Program, London, Ontario, Canada.
2 Department of Radiation Oncology, Sunnybrook Health Sciences Centre and the University of Toronto, Toronto, Ontario, Canada.
3 Department of Radiation Oncology, Penn State Cancer Institute, Hershey, PA, USA.
4 Department of Radiation Oncology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
5 University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center, Cleveland, OH, USA.
6 Beth Israel Deaconess Medical Center, Boston, MA, USA.
7 Geisinger Health, Danville, PA, USA.
8 Department of Radiation Oncology, Juravinski Cancer Centre, Hamilton, Ontario, Canada.
9 Department of Radiation Oncology, Harold C. Simmons Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX, USA.
10 Department of Radiology, University of Yamanashi, Yamanashi, Japan.
11 Department of Radiation Oncology, Houston Methodist Hospital, Cancer Center and Research Institute, Houston, TX, USA.
12 University of Munich Hospitals, Munich, Germany.
13 Department of Radiation Oncology, University of Washington School of Medicine, Seattle, WA, USA.
14 Division of Radiation Oncology & Cancer Imaging, Peter MacCallum Cancer Centre, and University of Melbourne, Melbourne, Australia. Electronic address: [email protected].